Sexual Dysfunction in Diabetes
文献摘要
Sexual dysfunction is a common but often underdiagnosed complication of diabetes, affecting both men and women through complex vascular, neurologic, hormonal, and psychosocial mechanisms. This chapter provides a detailed review of the pathophysiology, epidemiology, screening strategies, and treatment options for sexual dysfunction in individuals with diabetes. Erectile dysfunction (ED) is the most prevalent sexual dysfunction in men with diabetes and is strongly associated with cardiovascular disease, serving as an early warning sign for systemic vascular disease. Women with diabetes face significant risks of hypoactive sexual desire, arousal dysfunction, dyspareunia, and orgasm difficulty, which are often underdiagnosed despite their profound impact on quality of life. First-line therapies include lifestyle interventions such as weight loss, dietary modification, exercise, and smoking cessation, as well as pharmacologic treatments like PDE5 inhibitors, GLP-1 receptor agonists, and SGLT2 inhibitors. The chapter emphasizes the importance of integrating sexual health inquiry into routine diabetes care, offering practical tools such as validated questionnaires and sample questions for clinicians. While significant progress has been made in addressing ED, research gaps persist, particularly for female sexual dysfunction and diabetes-specific interventions. By fostering clinician-patient communication and addressing both physiological and psychological aspects of sexual health, this chapter highlights actionable steps to improve outcomes. For complete coverage of all related areas of Endocrinology, please visit our on-line FREE web-text, WWW.ENDOTEXT.ORG.